Daniel Haymann, MBA
Daniel Haymann, MBA

Daniel Haymann, MBA

Senior Associate, Zurich

Schiffbaustrasse 2 | Postfach | CH-8031 Zurich | Switzerland
Schiffbaustrasse 2 | Postfach | CH-8031 Zurich | Switzerland
T +41 58 552 00 43


Daniel Haymann’s practice focuses on international and domestic commercial litigation and arbitration as well as corporate and commercial law.

He established the first dedicated cannabis desk at a large law firm in Switzerland and advises investors, start-ups and vertically integrated companies in the cannabis industry along the value chain, including, among others, on regulatory matters (advice includes all regulatory aspects relating to THC, CBD and other cannabinoids; cultivation and distribution, including GMP and GDP standards, as well as retail; EU Novel Food; cosmetics law; medicinal cannabis products under the supervisory authority Swissmedic (as well as Herbal Medicines)).

He gained extensive experience as a commodity trader and in managerial positions in the coal, petroleum coke and fertiliser industries for the two leading international commodity trading firms in their respective fields. He was based in Zurich, Baar, Singapore and Hong Kong. He then joined an International Finance and Business Development Boutique as partner and held management positions in corporate business development.

Industry Groups

Special Desks

Rankings & Awards

Chambers and Partners Thought Leaders 2022Chambers and Partners Contributor Badge Chambers 2022

Education & Admission

  • Admitted to the Bar in Switzerland (2019)
  • Hong Kong University of Science and Technology, MBA
  • University of Zurich, MLaw

Memberships and public offices

  • Swiss Bar Association
  • Zurich Bar Association
  • International Cannabis Bar Association (Member of the International Committee)


  • German
  • English
  • Hebrew
  • French
  • Spanish
  • Chinese
More by Daniel Haymann


Legal Developments in the Swiss Cannabis Market

Chambers and Partners, Expert Focus 2022 Medical Cannabis Switzerland, 15 November 2022
  • EN

Die Zulässigkeit von Cannabis in kosmetischen Mitteln

Jusletter, 27. Juni 2022
  • DE

Medical Cannabis & Cannabinoid Regulation 2022 Switzerland – Law & Practice and Trends & Developments

Chambers and Partners, Global Practice Guides, Medical Cannabis & Cannabinoid Regulation, 20 June 2022
  • EN

Handel mit medizinischem Cannabis: Die Schweiz öffnet sich

krautinvest.de, Interview by Moritz Förster, 29. Mai 2022
  • DE